<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">20676403</PMID>
        <DateCompleted>
            <Year>2010</Year>
            <Month>10</Month>
            <Day>28</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2010</Year>
                        <Month>Jul</Month>
                        <Day>27</Day>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e11818</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0011818</ELocationID>
            <Abstract>
                <AbstractText>In a clinical infection, multiplying and non-multiplying bacteria co-exist. Antibiotics kill multiplying bacteria, but they are very inefficient at killing non-multipliers which leads to slow or partial death of the total target population of microbes in an infected tissue. This prolongs the duration of therapy, increases the emergence of resistance and so contributes to the short life span of antibiotics after they reach the market. Targeting non-multiplying bacteria from the onset of an antibiotic development program is a new concept. This paper describes the proof of principle for this concept, which has resulted in the development of the first antibiotic using this approach. The antibiotic, called HT61, is a small quinolone-derived compound with a molecular mass of about 400 Daltons, and is active against non-multiplying bacteria, including methicillin sensitive and resistant, as well as Panton-Valentine leukocidin-carrying Staphylococcus aureus. It also kills mupirocin resistant MRSA. The mechanism of action of the drug is depolarisation of the cell membrane and destruction of the cell wall. The speed of kill is within two hours. In comparison to the conventional antibiotics, HT61 kills non-multiplying cells more effectively, 6 logs versus less than one log for major marketed antibiotics. HT61 kills methicillin sensitive and resistant S. aureus in the murine skin bacterial colonization and infection models. No resistant phenotype was produced during 50 serial cultures over a one year period. The antibiotic caused no adverse affects after application to the skin of minipigs. Targeting non-multiplying bacteria using this method should be able to yield many new classes of antibiotic. These antibiotics may be able to reduce the rate of emergence of resistance, shorten the duration of therapy, and reduce relapse rates.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Yanmin</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Microbiology, Centre for Infection, Division of Cellular and Molecular Medicine, St George's, University of London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shamaei-Tousi</LastName>
                    <ForeName>Alireza</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Yingjun</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Coates</LastName>
                    <ForeName>Anthony</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2010</Year>
                <Month>07</Month>
                <Day>27</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000891">Anti-Infective Agents, Local</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C000623174">HT61 compound</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011804">Quinolines</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000891" MajorTopicYN="N">Anti-Infective Agents, Local</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055624" MajorTopicYN="N">Methicillin-Resistant Staphylococcus aureus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
                <QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D046529" MajorTopicYN="N">Microscopy, Electron, Transmission</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011804" MajorTopicYN="N">Quinolines</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
                <QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2010</Year>
                <Month>04</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2010</Year>
                <Month>06</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2010</Year>
                <Month>8</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>8</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2010</Year>
                <Month>10</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">20676403</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0011818</ArticleId>
            <ArticleId IdType="pmc">PMC2910736</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2009 Mar;53(3):918-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19104027</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Artif Organs. 2006 Apr;29(4):379-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16705606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1999 Jan 1;274(1):29-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9867806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2004 May 1;38(9):1279-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15127341</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Pharmacol. 2007 Dec;152(8):1147-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17704820</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Microbiol. 1994 Apr;32(4):1095-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8027320</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 1998 Oct;42(4):489-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9818748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Pharmacol Sci. 2008 Mar;29(3):143-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18262665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1994 Oct;38(10):2380-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7840574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Pathol. 1990 Sep;43(9):774-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2212072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2009 Jul;64(1):9-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19451132</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1993 Mar 13;341(8846):647-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8095569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Control Hosp Epidemiol. 1995 Jun;16(6):354-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7657989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2002 Nov;1(11):895-910</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12415249</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2005 Dec;56(6):1166-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16275681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mini Rev Med Chem. 2007 Apr;7(4):389-409</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17430225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1979 Dec;76(6 Suppl):771-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">92392</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Tuberc Lung Dis. 2000 Sep;4(9):796-806</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10985648</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Rev. 2002 Apr;15(2):167-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11932229</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>DNA Cell Biol. 2002 May-Jun;21(5-6):415-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12167244</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs. 2007;67(10):1483-512</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17600394</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2005 Aug;49(8):3435-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16048958</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Medicine (Baltimore). 1979 Mar;58(2):145-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">431400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):908-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7698116</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Pharmacol. 2006 Mar 30;71(7):919-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16289393</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2003 Feb;47(2):653-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12543673</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 1998 Jan;41(1):11-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9511032</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Infect. 2007 Mar;13(3):250-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17391378</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 1998 Aug;27 Suppl 1:S135-40; discussion S141-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9710682</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Control Hosp Epidemiol. 2003 May;24(5):342-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12785407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2009 Jun;53(6):2266-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19289521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bacteriol. 1996 Jul;178(13):3683-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8682766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tubercle. 1985 Sep;66(3):219-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3931319</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Respir Crit Care Med. 2004 Jun;25(3):307-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16088472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1985 Jun;27(6):921-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3927838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2009 Feb;15(2):211-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19182798</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Korean Med Sci. 2006 Oct;21(5):827-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17043414</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S7-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17707613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Appl Environ Microbiol. 1992 Aug;58(8):2649-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1514811</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1999 Mar;115(3 Suppl):24S-27S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10084456</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Infect Dis. 1986 Jul-Aug;8 Suppl 3:S279-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3529321</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pneumonologie. 1974 Jun 14;150(1):1-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4135222</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2005 Aug;26(2):106-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16009535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2003 Dec 1;37(11):1467-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14614669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 1985 May;15(5):523-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3924877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs R D. 2006;7(3):133-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16752940</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Intern Med. 1994 Jul 11;154(13):1505-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8018006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Microbiol. 1993 Apr;8(2):277-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8316080</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2007 Dec;51(12):4255-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17923487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 1989 Feb;33(2):156-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2497702</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>